Hsp110 chaperones control client fate determination in the hsp70-Hsp90 chaperone system. by Mandal, Atin K et al.
Molecular Biology of the Cell
Vol. 21, 1439–1448, May 1, 2010
Hsp110 Chaperones Control Client Fate Determination in
the Hsp70–Hsp90 Chaperone System
Atin K. Mandal,*† Patrick A. Gibney,†‡ Nadinath B. Nillegoda,*
Maria A. Theodoraki,* Avrom J. Caplan,* and Kevin A. Morano‡
*Department of Biology, The City College of New York, New York, NY 10031; ‡Department of Microbiology
and Molecular Genetics, University of Texas Medical School and Graduate School of Biomedical Sciences,
Houston, TX 77030
Submitted September 10, 2009; Revised March 5, 2010; Accepted March 8, 2010
Monitoring Editor: Jeffrey L. Brodsky
Heat shock protein 70 (Hsp70) plays a central role in protein homeostasis and quality control in conjunction with other
chaperone machines, including Hsp90. The Hsp110 chaperone Sse1 promotes Hsp90 activity in yeast, and functions as a
nucleotide exchange factor (NEF) for cytosolic Hsp70, but the precise roles Sse1 plays in client maturation through the
Hsp70–Hsp90 chaperone system are not fully understood. We find that upon pharmacological inhibition of Hsp90, a
model protein kinase, Ste11N, is rapidly degraded, whereas heterologously expressed glucocorticoid receptor (GR)
remains stable. Hsp70 binding and nucleotide exchange by Sse1 was required for GR maturation and signaling through
endogenous Ste11, as well as to promote Ste11N degradation. Overexpression of another functional NEF partially
compensated for loss of Sse1, whereas the paralog Sse2 fully restored GR maturation and Ste11N degradation. Sse1 was
required for ubiquitinylation of Ste11N upon Hsp90 inhibition, providing a mechanistic explanation for its role in
substrate degradation. Sse1/2 copurified with Hsp70 and other proteins comprising the “early-stage” Hsp90 complex, and
was absent from “late-stage” Hsp90 complexes characterized by the presence of Sba1/p23. These findings support a model
in which Hsp110 chaperones contribute significantly to the decision made by Hsp70 to fold or degrade a client protein.
INTRODUCTION
Molecular chaperones recognize unfolded or partially folded
proteins and promote acquisition of the functional native state
(Frydman, 2001). Nascent polypeptides or damaged proteins
are especially at risk and interaction with a chaperone such
as Heat shock protein 70 (Hsp70) stabilizes these substrates,
preventing aggregation and allowing progress along a pro-
ductive folding trajectory. Severely damaged proteins inca-
pable of achieving a stable conformation are selected for
triage in a process termed protein quality control, wherein
Hsp70 and accessory proteins such as the mammalian E3
ubiquitin ligase Chip target the substrate for degradation via
the ubiquitin-proteasome system (Connell et al., 2001; Mc-
Donough and Patterson, 2003). Factors influencing the deci-
sion to fold or degrade substrate proteins are poorly under-
stood, but include cochaperones that regulate substrate
association with Hsp70 (Mandal et al., 2008).
Hsp70 chaperones are composed of an amino-terminal
nucleotide binding/ATPase domain and a bipartite carbox-
yl-terminal substrate-binding domain (SBD) consisting of a
-sheet–rich polypeptide-binding site followed by an -he-
lical lid (Mayer and Bukau, 2005). Hsp70 exists in two func-
tional states; the ADP-bound state exhibits high-affinity for
substrate, whereas the ATP-bound form exhibits low affinity
with enhanced rates of peptide release. Cochaperones of the
Hsp40 family such as Ydj1 in the yeast Saccharomyces cerevi-
siae stimulate ATP hydrolysis by Hsp70 and thus favor tight
substrate binding (Cyr et al., 1992). In addition, a subset of
Hsp40s are themselves passive chaperones that bind sub-
strate and facilitate loading onto Hsp70 (Cyr, 1995). Hsp70
cycling is further accelerated by nucleotide exchange factors
(NEFs) that recharge the nucleotide-binding domain with
ATP and promote substrate release (Szabo et al., 1994). The
Hsp110 family of stress-induced proteins were recently
identified as potent NEFs (Dragovic et al., 2006; Raviol et al.,
2006; Shaner et al., 2006; Shaner and Morano, 2007). Hsp110s,
including the yeast paralogs Sse1 and Sse2, are a structurally
distinct subgroup of the Hsp70 superfamily that form stable
heterodimeric complexes with cytosolic Hsp70 and acceler-
ate protein folding (Easton et al., 2000; Shaner et al., 2005;
Yam et al., 2005). The Sse proteins possess an Hsp70-like
substrate-binding domain capable of preventing aggrega-
tion of unfolded substrates, but it is not known whether this
domain makes contact with client proteins or contributes to
client folding in the context of the active Hsp110–Hsp70
complex (Brodsky et al., 1999). In addition to the Sse1/2
proteins, the HspBP1 homolog Fes1, and the ER-associated
Snl1, containing a conserved Bag domain, likely contribute
to Hsp70-dependent protein homeostasis and transport in
yeast (Kabani et al., 2002a,b; Sondermann et al., 2002).
Hsp70 and its cofactors collaborate with the protein chap-
erone Hsp90 to promote the maturation of a subset of cel-
lular proteins, most notably protein kinases and transcrip-
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tion factors (Picard, 2002; Wandinger et al., 2008). Indeed, a
number of key cellular regulatory proteins implicated in
human disease are Hsp90 clients, and intense efforts are
underway to understand in detail how these proteins are
recognized and processed. Interruption of the Hsp70–
Hsp90-folding cycle through genetic or pharmacological
means, such as the specific inhibitor geldanamycin (GA), can
result in ubiquitinylation and degradation of the client pro-
tein (Whitesell and Lindquist, 2005). Identification of the
Hsp70 activator Ydj1 as an important regulator of protein
kinase stability when forward progress through the Hsp90
system is compromised suggests that Hsp70 is a major nexus
of client fate evaluation and that other Hsp70-regulating
partners may likewise influence this decision (Mandal et al.,
2008). Sse1 has been physically and genetically linked to the
Hsp90 chaperone complex in yeast, although its precise
mode of action is unclear (Liu et al., 1999; Goeckeler et al.,
2002; Lee et al., 2004). Sse1 is also implicated through an
unknown mechanism in protein quality control as deletion
stabilizes folding-defective von Hippel-Landau (VHL) tu-
mor suppressor protein expressed in yeast (McClellan et al.,
2005).
In this report we sought to determine the precise role(s)
Sse1 plays in client maturation through the Hsp70–Hsp90
chaperone system. We find that Sse1 is required for the
degradation of the model protein kinase, Ste11N, when
Hsp90 is inhibited. In keeping with the recently described
function of the Hsp110 chaperones as NEFs, Hsp70 binding
and nucleotide exchange activity of Sse1 was required for
both glucocorticoid receptor (GR) and Ste11 activity. Over-
expression of another functional NEF only partially compen-
sated for loss of Sse1 in these roles, whereas the paralog Sse2
fully restored both client maturation and degradation. We
provide a mechanistic explanation for the observed require-
ment for Sse1 by demonstrating that it is required for ubiq-
uitinylation of Ste11N upon Hsp90 inhibition. Hsp110
chaperones may play a global role in regulating protein
degradation as ubiquitinylation of misfolded newly synthe-
sized proteins was likewise impaired in sse1 cells. Sse1/2
copurified with Hsp70 and other proteins comprising the
“early-stage” Hsp90 complex, and was absent from “late-
stage” Hsp90 complexes characterized by the presence of
Sba1/p23. Together these findings support a model in which
Hsp110 chaperones control the fate of some client proteins
by influencing the decision to fold or degrade as dictated by
the Hsp70–Hsp90 chaperone environment.
MATERIALS AND METHODS
Yeast Strains and Plasmids
All strains used in this study are isogenic derivatives of BY4741 (MATa ura30
leu20 his31 met150). Strains containing disruptions in SSE1, SSE2, STI1,
and SBA1 were all obtained from the Yeast Knockout Collection and have the
entire open reading frame (ORF) replaced by the kanMX G418-resistance
cassette (Brachmann et al., 1998). Yeast propagation, transformation, and
manipulations were carried out according to standard protocols (Kaiser et al.,
1994). Growth assays were carried out by replica pronging as described
(Shaner et al., 2008). Plasmids used in this study are listed in Table 1. All
plasmids created in this report were constructed by amplifying the entire ORF
or portions thereof from genomic DNA by PCR using oligonucleotide primers
incorporating restriction enzyme sites to allow cloning into expression vec-
tors. Where indicated, a single iteration of the Flag epitope (DYKDDDK) was
included in the 5 primer. P415TEF-SSE1-G233D was constructed by ampli-
fying from plasmid p414TEF-SSE1G233D (Shaner et al., 2004). To construct
p413GPD-FLAGSNL1N, a plasmid expressing the Snl1 NEF lacking its
transmembrane domain, a 5 primer was designed to anneal within the ORF
and amplify sequence encoding predicted amino acid residues from 40 to the
endogenous stop codon. A 3 primer was designed to incorporate a C-
terminal FLAG tag. Plasmid p416GPD-FLAGSSE2NBD was constructed with
a 5 Flag-containing primer and a 3 primer designed to truncate the ORF at
residue 387, resulting in expressing of the intact nucleotide-binding domain of
Sse2. All oligonucleotide sequences are available upon request. Yeast ß-
galactosidase assays, nonradioactive immunoprecipitation, and immunoblots
were performed exactly as described (Shaner et al., 2004, 2005). Induction and
assay of glucocorticoid receptor and mating pathway activity was as de-
scribed (Liu et al., 1999; Lee et al., 2004). Anti-His antibody was used to detect
and immunoprecipitate Ste11NK444R. BuGR antibody was used to detect and
immunoprecipitate the GR (Affinity Bioreagents, Golden, CO).
Pulse-Chase Assays
Yeast cells were grown in selective media to midlog phase (A600  0.4–0.6),
washed twice with water, and resuspended in SD-Met at a concentration of 6
OD/ml. Cells were incubated for 45 min at 30°C with constant shaking. GA
was added 30 min before pulse labeling with [35S]methionine (100 Ci/ml).
The pulse was quenched with cycloheximide (200 g/ml) and cold methio-
nine (10 mM) for chase reactions. Samples of 400 l were taken at various time
points of chase reactions and added to an equal volume of ice-cold trichlo-
roacetic acid until all the samples had been processed. The cells were pelleted
and washed twice with chilled acetone (20°C) before vacuum drying. Ex-
tracts were prepared by resuspending the cell pellet in 200 l of ice-cold
extraction buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 1% SDS, and 1 protease
inhibitor cocktail; Roche Diagnostics, Indianapolis, IN) followed by lysing in
a bead beater at 4°C two times for 30 s after adding equal volume of glass
beads. Extracts were clarified at 13, 000  g for 10 min. 35S incorporation was
measured in a scintillation counter, and equal amount of counts were used for
subsequent immunoprecipitation. Extracts were prepared for immunopre-
cipitation by diluting at least 10-fold with immunoprecipitation (IP) dilution
buffer (60 mM Tris-HCl, pH 7.5, 190 mM NaCl, 1.25% Triton X-100, and 6 mM
EDTA). Antisera were added, and the samples were incubated overnight at
4°C with rotation. Immunoprecipitates were adsorbed onto protein A/G-
Sepharose (Pierce, Rockford, IL) resin for 1 h and washed four times with IP
dilution buffer. The samples were boiled in 1 SDS-sample buffer and re-
solved by denaturing gel electrophoresis. The gels were fixed (10% acetic acid,
Table 1. Plasmids used in this study
Plasmid Description Reference
pSte11NK444R Ste11NK444R expression plasmid Flom et al. (2008)
pRS423-myc-Ub Myc epitope-tagged UBI4 with CUP1 promoter, HIS3 Nakatsukasa et al. (2008)
p415TEF LEU2-based expression plasmid, TEF promoter Mumberg et al. (1995)
p413GPD HIS3-based expression plasmid, GPD promoter Mumberg et al. (1995)
p416GPD URA3-based expression plasmid, GPD promoter Mumberg et al. (1995)
p415TEFSSE1 SSE1 ORF clone (SpeI/XhoI) This study
p415TEFSSE1-G233D SSE1-G233D ORF clone (SpeI/XhoI) This study
p413GPDFLAGSSE2 N-terminal FLAG-tagged SSE2 ORF clone (SpeI/XhoI) This study
p413GPDFLAGSNL1N C-terminal FLAG-tagged SNL1 ORF residues 40-end (SpeI/XhoI) This study
P416GPDFLAGSSE1 N-terminal FLAG-tagged SSE1 ORF clone (SpeI/XhoI) This study
P416GPDFLAGSSE2NBD N-terminal FLAG-tagged SSE2 ORF fragment (1–387) (SpeI/XhoI) This study
P416GPDFLAGSTI1 N-terminal FLAG-tagged STI1 ORF (SpeI/XhoI) This study
P416GPDFLAGSBA1 N-terminal FLAG-tagged SBA1 ORF (SpeI/XhoI) This study
pYRP-G2 GRE-lacZ reporter, 2 , URA3 Morano et al. (1999)
p413GPD-rGR Rat GR protein, CEN, HIS3 Morano et al. (1999)
pPRE-lacZ PRE-lacZ reporter, 2 , URA3 Morano and Thiele (1999)
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30% methanol) for 30 min, washed twice in water for 15 min, and incubated
in 1 M sodium salicylate for 30 min before drying and exposing to x-ray film
or phosphorimager screen.
Mass Spectrometry and Protein Identification
Proteins coprecipitating with Flag-Sse2NBD were identified in the Proteomics
Core Facility at the University of Texas Health Science Center at Houston.
Mass spectrometry (MS-MS) analysis was performed on an Applied Biosys-
tems QStar Elite LC/MS/MS mass spectrometer (Foster City, CA) equipped
with an LC Packings (Dionex, Sunnyvale, CA) HPLC for capillary chroma-
tography, coupled to the mass spectrometer by a Nanospray II electrospray
ionization (ESI) source for direct analysis of the eluate. For protein identifi-
cation, a Pasteur pipette was used to cut and excise a spot of gel from the band
of interest. The gel piece was destained and then reduced with DTT. After
reduction the cysteines were blocked by alkylation with iodoacetamide and
subjected to in-gel proteolytic digestion with trypsin for 16 h at 37°C essen-
tially as described (Simpson, 2003). Peptides were separated by HPLC on a
C18 75 m  10 cm reverse-phase capillary column developed with a gradi-
ent of 2–50% acetonitrile in 0.1% formic acid over 30 min at a flow rate of 250
nl/min. The QSTAR was operated in Information Dependent Acquisition
mode using a 1-s survey scan followed by two consecutive 3-s product ion
scans of 2, 3, and 4 parent ions (m/z 380-1500). Peptides and modifica-
tions were identified by Protein Pilot (Applied Biosystems) and verified with
Mascot (Matrix Science, Boston, MA) with an MS and MSMS mass tolerance
of 50 ppm and 0.1 Da, respectively.
In Vivo Ubiquitinylation Assay
In vivo ubiquitinylation of the substrate was assayed after immunoprecipita-
tion followed by immunoblotting with anti-myc antibody. Wild-type (WT)
and sse1 yeast cells transformed with copper-inducible myc-ubiquitin plas-
mid were grown to midlog phase (OD  0.8) in selective media in the
presence of 0.1 mM CuSO4 (Nakatsukasa et al., 2008). Equal amounts of cells
were divided in three parts and incubated with DMSO, GA (20 M), and
MG132 (100 M) for 1 h. Cells were harvested and washed with cold water
containing 4 mM N-ethylmaleimide (NEM) to inhibit deubiquitinylating en-
zymes. Cell extracts were prepared by resuspending the pellet in 150 l
ice-cold extraction buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 1% SDS, 8 M urea,
1 mM PMSF, 10 mM NEM, and 1 protease inhibitor cocktail) followed by
lysing in a bead beater at 4°C after adding an equal volume of glass beads.
Extracts were clarified at 13, 000  g for 10 min. The supernatant, 100 l , was
diluted 10-fold with IP dilution buffer (60 mM Tris-HCl, pH 7.5, 190 mM
NaCl, 1.25% Triton X-100, 6 mM EDTA, 1 mM PMSF, 10 mM NEM, and
protease inhibitor cocktail). Monoclonal Anti-His antibody was added, and
the samples were nutated overnight at 4°C. Immunoprecipitates were ad-
sorbed onto protein A/G Sepharose (Pierce) resin for 2 h at 4°C and washed
three times with IP wash buffer (10 mM Tris, pH 7.5, and 50 mM NaCl). The
samples were boiled in 2 urea-sample buffer (75 mM MOPS, pH 6.8, 8 M
urea, 4% SDS, 0.2 M -mercaptoethanol, and 0.2 mg/ml bromophenol blue)
and resolved by SDS-PAGE.
Citrulline Uptake/Permease Assay
Yeast cells were grown in YPD, washed twice with water, resuspended in
minimal media with proline to an OD600 of 0.5 and further incubated for 90
min at 30°C. The cells were harvested, washed, and resuspended in citric acid
buffer (10 mM citric acid, pH 4.5, and 2% glucose) to an OD600 of 2. Cell
aliquots of 0.5 ml were incubated with 1 Ci [14C]l-citrulline (56.3 mCi/
mmol) for 20 min at room temperature. The cells were collected on a glass
microfiber filter and washed three times with water. Filters were dried, and
radioactivity was measured in a liquid scintillation counter. Assays were
done in triplicate to determine SEM.
RESULTS
Previous studies showed that Ydj1 and Cdc37 act to protect
newly synthesized protein kinases from rapid proteasomal
degradation in yeast treated with the Hsp90 inhibitor GA
(Mandal et al., 2007, 2008). We therefore sought to establish
what roles other cochaperones of the Hsp70 and Hsp90 ma-
chinery play in this process. Sse1 was chosen for further studies
as it was shown previously to be important for degradation of
a misfolded protein heterologously expressed in yeast (McClel-
lan et al., 2005). Furthermore, because Sse1 acts as an NEF for
Hsp70, its biochemical function is opposite to that of Ydj1,
which promotes ATP hydrolysis. We used a recombinant pro-
tein kinase Ste11NK444R for these studies because it displays
high chaperone dependence for folding but is kinase-dead and
thus has no effect on yeast cell growth (Flom et al., 2008). In a
previous study we observed that Sse1 was required for proper
activity of the kinase active form of Ste11N (Lee et al., 2004).
Pulse-chase analysis with 35S-Met was used to determine the
stability of newly synthesized Ste11NK444R in WT and sse1
cells. Ste11NK444R was stable in both WT and sse1 yeast,
with well over 50% remaining after 2 h of chase (Figure 1A).
The slight difference in Ste11NK444R abundance in WT and
sse1 cells was not statistically significant except at the 2-h time
point. Similar findings were made for Rim11 and Tpk2 kinases,
which also had similar activity in WT and sse1 cells (see
Supplementary Figure S1) By contrast, Ste11NK444R syn-
thesized in cells exposed to GA was very unstable, with a
half-life of 12 min in WT cells (Figure 1B). In sse1 cells,
however, rapid degradation was inhibited and the half-life
of Ste11NK444R was calculated to be 48 min in the pres-
ence of GA. Deletion of the SSE1 paralog, SSE2, was without
Figure 1. Sse1 promotes degradation of newly synthe-
sized protein kinase. (A) Pulse-chase analysis of
Ste11NK444R in WT and sse1 yeast cells. Chase times
as indicated. Ste11NK444R was immunoprecipitated
with anti-His and kinase bands quantified by phospho-
rimaging. The rate of kinase degradation normalized to
t  0 is shown in the accompanying graph. (B) Pulse-
chase experiment of Ste11NK444R in WT, sse1, and
sse2 yeast cells in the presence of 10 M geldanamycin
(GA) added 30 min before labeling. Error bars, SEM of
three independent experiments.
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effect on Ste11NK444R degradation, consistent with the fact
that Sse1 appears to be the dominant Hsp110 ortholog in
budding yeast (Mukai et al., 1993).
Sse1 was observed in previous studies to be required for
the activity of GR and the kinase active Ste11N (Liu et al.,
1999; Lee et al., 2004). We therefore compared the role of Sse1
in GR degradation with that of Ste11NK444R. These exper-
iments used the same pulse-chase protocol and followed the
fate of newly synthesized rat GR heterologously expressed
in yeast. Steady-state levels of GR were similar in WT and
sse1 cells (Figure 2A), and as with Ste11NK444R, newly
synthesized GR was degraded with similar kinetics under
normal conditions in both cell types (Figure 2B). Geldana-
mycin treatment of WT cells did not affect the kinetics of GR
degradation as profoundly as with Ste11NK444R, nor did
we observe significant differences in GR stability in sse1
cells (Figure 2C). These combined findings show that despite
a demonstrated requirement to support activity of two ca-
nonical clients of the Hsp90 system, a protein kinase and
steroid hormone receptor, Sse1 plays very little role in their
stability under normal conditions. In contrast, when client
transfer to Hsp90 is compromised by GA treatment, protein
kinase degradation is promoted by Sse1, whereas GR is not
targeted to the same fate.
The Role of Sse1 in Hsp90 Client Protein Fate
Determination
Sse1 functions as a NEF for Hsp70 and also as a passive
molecular chaperone. To determine which of these two ac-
tivities is involved in promoting protein kinase degradation
in vivo, we used two previously characterized SSE1 mutant
alleles. Sse1 containing the substitution K69Q binds ATP
(but cannot hydrolyze it) and is capable of associating with
Hsp70 and accelerating nucleotide exchange. A second mu-
tant, G233D, does not bind ATP and does not form exchange
complexes with Hsp70 (Shaner et al., 2004, 2005; Dragovic et
al., 2006; Raviol et al., 2006). As reported previously, cells
lacking SSE1 do not support activation of GR by the syn-
thetic hormone analog deoxycorticosterone (DOC; Figure
3A; Liu et al., 1999). Although sse1-K69Q behaved essentially
the same as wild type, introduction of the sse1-G233D mu-
tant failed to restore GR activation, suggesting that Sse1
participates in GR maturation by virtue of its activity as a
NEF for Hsp70. Identical results were obtained when mating
pathway signaling through the endogenous Ste11 protein
kinase was assayed. Although WT cells or sse1 cells ex-
pressing plasmid-borne WT SSE1 or sse1-K69Q were respon-
sive to the -factor inducer, sse1 cells bearing an empty
vector or the sse1-G233D allele were not (Figure 3B).
We also assayed Sse1’s mode of action in GA-induced
degradation of Ste11NK444R. Although reintroduction of
WT SSE1 or sse1-K69Q completely restored fast kinase deg-
radation to sse1 cells, the G233D mutant did not (Figure
3C). Together, these results demonstrate that the Hsp70-
binding and NEF activity of Sse1 is required to support
productive maturation of these Hsp90 client proteins. More-
over, this mechanistic insight into Sse1 function extends to
the triage decision occurring in the presence of GA, as the
sse1-G233D mutant is unable to promote rapid degradation
of Ste11NK444R.
Other yeast proteins act as NEFs for cytosolic Hsp70 chap-
erones in addition to Sse1. One of these is Sse2, a less
abundant paralog of Sse1 that can compensate for some Sse1
functions when overexpressed (Mukai et al., 1993; Shaner et
al., 2008). Another is Snl1, which contains a mammalian Bag
domain and can function as an Hsp70 NEF (Sondermann et
al., 2002; Sadlish et al., 2008). Snl1 is anchored to the cyto-
plasmic face of the endoplasmic reticulum through an ami-
no-terminal transmembrane domain. Truncation of this do-
main (Snl1N) renders the protein soluble and retains NEF
activity (Sondermann et al., 2002). We therefore asked
whether Sse1 functions in GR maturation and whether reg-
ulation of Ste11NK444R degradation could be replaced by
these other yeast NEFs. Overexpression of the SSE2 and
SNL1N genes both effectively suppressed the slow-growth
phenotype of sse1 cells at 30°C (Figure 4A). In contrast,
only SSE2 permitted growth at the more restrictive temper-
ature of 39°C. We established previously that this high-
temperature growth phenotype is due to severe reduction in
signaling through the cell integrity pathway because of loss
of Slt2 (Mpk1) kinase activity in strains compromised for
Sse1 function (Shaner et al., 2008). Slt2 is an Hsp90 client;
thus the observed growth defect of sse1 cells at 39°C is a
direct consequence of Sse1’s participation in Hsp90 chaper-
oning (Piper et al., 2006; Truman et al., 2007). Consistent with
this result, Sse2 completely restored GR activation, whereas
Snl1N only partially suppressed loss of Sse1 (Figure 4B).
These results were further mirrored when Ste11NK444R
degradation kinetics were measured in the presence of the
different NEFs: Sse2 restored fast degradation to sse1 cells,
whereas overexpression of SNL1N resulted in a half-life
intermediate between that observed with sse1 and WT cells
(Figure 4C). Thus, although unrelated NEFs can compensate
for at least some of Sse1’s in vivo roles, as evidenced by
suppression of the 30°C slow growth phenotype of sse1
cells, only the Hsp110 family, composed in budding yeast of
Figure 2. Sse1 does not promote glucocorticoid receptor (GR)
degradation. (A) Steady-state level of GR in WT and sse1 yeast
cells. Cells were grown at 30°C to midlog phase before protein
extraction. GR is identified with anti-GR antibody. Western blot
of the same samples was performed with anti-Pgk1 as a loading
control. (B) Pulse-chase analysis of GR in WT and sse1 yeast
cells. Chase times are given in hours. (C) Pulse chase of GR in WT
and sse1 yeast cells in presence of 50 M geldanamycin (GA)
added 30 min before labeling. Error bars, SEM of three indepen-
dent experiments.
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Sse1 and Sse2, appears to participate effectively in Hsp90-
dependent activities.
Sse1 Promotes Substrate Ubiquitinylation upon Folding
Inhibition
Sse1 clearly controls the degradation of a model protein kinase
whose folding is inhibited. We next sought to establish at what
stage in this process Sse1 acts. Our studies focused on
testing first whether Sse1 acted before ubiquitinylation of
Ste11NK444R or afterward. This was accomplished by immu-
noprecipitating the kinase in WT and sse1 cells treated with
both GA and the proteasome inhibitor MG132. Both strains
included a plasmid expressing Myc-tagged ubiquitin to facili-
tate detection of the ubiquitinylated form of the immunopre-
cipitated kinase by Western blot. Our findings showed that
inhibiting Ste11NK444R folding with GA and degradation
with MG132 in WT cells led to accumulation of nondiscrete
polyubiquitinylated species (Figure 5A). However, this accu-
mulation was greatly reduced in the sse1 strain, even though
there were similar quantities of myc-ubiquitin expressed in
both strains (Figure 5B). To establish whether Sse1 functions
more broadly in the ubiquitinylation of misfolded proteins, we
used a toxic proline analog, azetidine 2-carboxylic acid (AZC).
AZC incorporates competitively into newly synthesized pro-
teins, resulting in misfolding and/or thermal instability. We
pulse-labeled cells treated or not with AZC and immunopre-
cipitated ubiquitinylated proteins using anti-Myc antibody
from extracts normalized for total radioactivity and observed
that AZC stimulated a substantial increase in the ubiquitinyla-
tion of bulk newly synthesized proteins (Figure 5C). Strikingly,
the amount of ubiquitinylation of newly synthesized proteins
was diminished in the sse1 strain compared with wild type.
To verify that this difference was not due to differences in
transport of AZC into cells, we carried out a 14C-citrulline
transport assay. AZC is transported into yeast cells primarily
through the action of the Gap1 permease, whereas citrulline
Figure 3. Sse1 interaction with Hsp70 is essential for Hsp90 client activity and kinase degradation. (A) Sse1 interaction with Hsp70 is
required for inducible glucocorticoid receptor activity. The indicated strains expressing rat GR and a GRE-lacZ reporter plasmid were treated
with DMSO () or 10 M deoxycorticosterone in DMSO (DOC;) for 1.5 h and ß-galactosidase activity determined. (A) Sse1 interaction with
Hsp70 is required for inducible mating pathway activity governed by Hsp90 client Ste11 kinase. The indicated strains bearing a pheromone
response element (PRE)-lacZ transcriptional fusion reporter were treated () or not () with 5 M -factor for 2 h before determination of
ß-galactosidase activity. Error bars, (A and B) SEM of three independent experiments. (C) Pulse chase of Ste11NK444R in WT (E), sse1 (Œ),
sse1 SSE1 (‚), sse1 SSE1K69Q (), and sse1 SSE1G233D (F) in the presence of 10 M GA added 30 min before labeling. Chase times are given
in minutes. Error, SEM of three independent experiments.
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exclusively uses this transporter (Andreasson et al., 2004; Gar-
rett, 2008). Not surprisingly, we observed no appreciable dif-
ference in citrulline uptake in WT versus sse1 cells (Figure
5D). These combined findings suggest that Sse1 functions up-
stream of the ubiquitinylation process, ultimately regulating
delivery or exposure of misfolded substrates to the protein
degradation machinery.
Sse1 Associates with Early-Stage Cochaperones within
the Hsp90 Complex
Sse1 readily copurifies from yeast cell extracts with the Ssa
and Ssb families of cytosolic Hsp70 chaperones (Shaner et al.,
2005; Yam et al., 2005). In contrast, earlier isolation of His6–
Hsp90 chaperone complexes using metal chelation affinity
resin resulted in minimal recovery of Sse1 (Liu et al., 1999).
These findings suggest that although Sse1 forms stable in-
teractions with Hsp70, its association with Hsp90 may be
transient. Crystal structures of the Sse1–Hsp70 heterodimer
established that Sse1 makes numerous contacts with Hsp70
with both its nucleotide-binding domain and substrate-
binding domain (Polier et al., 2008; Schuermann et al., 2008).
Indeed, both sets of interactions are required for Sse1 to
accelerate nucleotide exchange on Hsp70 because purified
Sse2NBD binds Hsp70 but lacks NEF activity (Sse1NBD is
highly unstable in both Escherichia coli and yeast cells;
Shaner et al., 2006). As shown in Figure 6A, affinity purifi-
cation of either Flag-tagged Sse1 or Sse2NBD from yeast cell
extracts resulted in the expected copurification of Ssa and
Ssb chaperones as detected by Coomassie staining. Strik-
ingly, in addition to the Hsp70 homologues, Flag-Sse2NBD
was recovered with a number of additional proteins not
observed with pulldown of Flag-Sse1 or an empty vector
control. Mass spectrometric identification of bands that were
unique or highly enriched in the Sse2NBD isolation versus
full-length Sse1 revealed the presence of the two yeast iso-
forms of Hsp90, Hsp82, and Hsc82, as well as the HOP
homolog Sti1. In addition we identified the translation factor
EF-3A, and the AAA ATPase Cdc48, but the significance of
these interactions is presently unclear because we did not
recover the other two components of the ERAD complex,
Ufd1 and Npl4. We confirmed the dramatically enhanced
interaction of truncated Sse2 with both Hsp90 isoforms and
associated cochaperones through Western blot analysis (Fig-
ure 6B). In addition to the proteins identified by mass spec-
trometry, we also found enhanced association with Ydj1.
These results are most consistent with a model wherein
Hsp70 associated with NEF-active Sse1 rapidly cycles
through association with Hsp90 and its associated cochap-
erones, whereas NEF-inactive but Hsp70 binding-competent
Sse2NBD increases the dwell time between Hsp70 and
Hsp90, effectively “trapping” the two chaperone machines
in an early stage configuration.
To further examine whether Sse1 is present exclusively in
early stages of the Hsp90 cycle or may play roles throughout
the maturation process, we performed Flag affinity purifica-
tion of either Sti1, present only in early stage Hsp90 com-
plexes, or Sba1, the yeast p23 homolog that stabilizes the
ATP-bound form of Hsp90 and characterizes late-stage com-
plexes (Chang and Lindquist, 1994; Chang et al., 1997; Fang
et al., 1998). As shown in Figure 6C, isolation of Flag-Sti1
resulted in the copurification of Hsp90, Hsp70 (Ssa1/2),
Sse1, and Ydj1 but not Sba1. This result is consistent with the
observation that Sba1 was also not detected in complex with
either Sse1 or Sse2NBD (Figure 6B). In contrast, isolation of
Flag-Sba1 (in the presence of 5 mM AMP-PNP, known to
stabilize the Sba1–Hsp90 interaction), resulted in copurifica-
tion of only Hsp90 (Figure 6D; Fang et al., 1998). Together
these experiments provide converging lines of evidence that
Sse1 participates exclusively in early stage steps of the
Hsp90 chaperone cycle, coincident with Hsp70. Moreover,
Figure 4. Differential complementation of
sse1 functions by Hsp110 and BAG domain
NEFs. (A) Differential complementation of sse1
growth defects. The indicated strains were rep-
lica-pronged as 10-fold dilutions onto selective
medium and incubated for 3 d at 30 or 39°C. (B)
Differential complementation of sse1 defects in
GR maturation. Strains used in A were trans-
formed with the GR reporter system and as-
sayed for GR activity as described for Figure 3.
(C) Differential complementation of sse1 defects
in kinase degradation. Strains used in A were
transformed with pSte11NK444R, and rates
of kinase degradation were determined as in
Figure 1.
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Sse1–Hsp70 complexes appear to transiently associate with
Sti1 and Hsp90, whereas complexes incapable of accelerated
nucleotide exchange (Sse2NBD) stabilize this interaction.
DISCUSSION
Molecular chaperone function in promoting degradation of
unfolded or misfolded proteins is currently under intense
investigation, but thus far little is understood regarding
partitioning between folding and degradation pathways.
The role of Sse1 as shown herein illustrates the problem, as
Sse1 promotes degradation of a newly synthesized unfolded
protein kinase while under the same conditions has little
bearing on stability of GR. However, Sse1 is required for
maturation and acquisition of hormone activation compe-
tency by GR. The nucleotide exchange capacity of Sse1 is
required for both functions, thereby defining its role in
association with Hsp70. Because Ydj1 acts to protect protein
kinases under the same conditions that Sse1 promotes deg-
radation, it seems likely that controlled polypeptide release
from Hsp70 underlies this phenomenon. Previous studies
have also established that Sse1 can both promote degrada-
tion (of VHL expressed in yeast) and act in a protective
capacity (ApoB48 expressed in yeast (McClellan et al., 2005;
Hrizo et al., 2007). Moreover, Hsp70 and both Sse1 and Ydj1
have recently been implicated in targeting of misfolded
cytosolic proteins to the E3 ubiquitin ligases San1 and Ubr1
for degradation (Heck et al., 2010).
It is worth pointing out that our methods utilized an
Hsp90 inhibitor to prevent folding/maturation of protein
kinases and the GR. This is important because it is very
likely that Hsp90 itself participates in altered polypeptide
fate determination. GA competes directly for nucleotide
binding to Hsp90, and this causes a rearrangement or block-
age of its functional cycle (Prodromou et al., 1997). Immu-
noprecipitation experiments from animal cells treated with
the drug demonstrate that Hsp90 is still bound to protein
kinase or steroid hormone receptor clients, along with Hop
(Sti1) and Hsp70, but that cochaperones such as Cdc37 or
p23 are dissociated (Smith et al., 1995; An et al., 2000; The-
odoraki et al., 2007). Based on the studies shown here, Sse1
participation is restricted to this early-stage complex,
thereby linking its function to the ability of GA to promote
altered fate determination. The question that remains is how
this complex differentially promotes protein kinase degra-
dation or protection of unfolded GR from the same fate.
What seems clear is that the nucleotide exchange function of
Sse1 and Sse2 is critical for influencing this decision, as
demonstrated by partial suppression of sse1 protein pro-
cessing defects by Snl1N and the lack of complementation
by NEF-defective sse1-G233D. Additional roles for the
Hsp110 cochaperones in substrate fate determination are
suggested by the inability of Snl1N to fully replace Sse1
compared with Sse2. The passive Hsp70-like SBD present in
both Sse1 and Sse2 may indeed be involved in client binding
and play a role akin to that of Ydj1, which binds substrate
itself in addition to stimulating Hsp70s ATPase activity to
promote the high-affinity binding conformation. However,
because the Hsp110 SBD is also required for Hsp70 binding
and exchange activity, it is not possible at this time to
deconvolute the respective contributions of client binding
and Hsp70 nucleotide exchange by Hsp110 proteins.
Our hypothesis, therefore, is that weakening of Hsp70
client interactions when folding pathways are inhibited re-
sults in a change of fate for polypeptides, as shown in Figure
7. NEF activity is normally required to complete the Hsp70
folding cycle (pathway A), resulting in handoff of the client
to Hsp90 and ultimately acquisition of the native conforma-
tion. Alternatively, NEF action promotes release of clients in
cells treated with GA, and these misfolded or immature
substrates are targeted for degradation by the ubiquitinyla-
tion machinery (pathway B). In sse1 cells, Hsp70 remains in
substrate-binding mode, and substrate ubiquitinylation is
blocked. In both of these scenarios, Hsp70 is the nexus of the
decision to fold or degrade. Indeed, Hsp70 is required for
degradation in other quality control pathways (Bercovich et
al., 1997; Qian et al., 2006; Han et al., 2007; Nakatsukasa et al.,
2008; Heck et al., 2010). Why are some clients targeted for
rapid degradation, whereas others simply fail to mature?
One significant difference between the GR and protein ki-
nases that may contribute to differential fate determination
may be the length of time each spends complexed with
Hsp90. GR–Hsp90 complexes persist, in a dynamic manner,
until ligand binding completes the folding reaction, leading
to receptor activation (Pratt et al., 2006). In contrast, most
Figure 5. Sse1 promotes ubiquitinylation of unfolded proteins. (A)
Top, ubiquitinylation of Ste11NK444R in WT and sse1 cells after
treatment with GA and MG132 as described in Materials and Meth-
ods. Ste11 was immunoprecipitated using anti-His antibody from
cell extracts, followed by Western blot with anti-Myc antibody to
detect Ste11-Ub conjugates. Bottom, the relative levels of
Ste11NK444R after immunoprecipitation. (B) Western blot of myc-
tagged ubiquitin in WT and sse1 yeast cells. Pgk1 serves as a
loading control. (C) Sse1 promotes ubiquitinylation of misfolded
newly synthesized proteins. WT and sse1 cells were pulse-labeled
for 10 min in the absence () and presence () of 50 mM azetidine
2-carboxylic acid (AZC). Bulk polyubiquitinylated proteins were
immunoprecipitated with anti-myc and resolved using 4–20% SDS-
PAGE. The accompanying bar graph shows fold induction of ubiq-
uitinylation after treatment with AZC in WT and sse1 cells. Error
bars, SEM of three independent experiments. (D) sse1 cells are not
defective in AZC incorporation. Transport of [14C]l-citrulline as a
proxy for AZC was determined in WT and sse1 cells as described
in Materials and Methods. Error bars, SEM of three independent
experiments.
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protein kinases appear to require molecular chaperones only
for initial folding steps (Caplan et al., 2007; Mandal et al.,
2007).
Interestingly, our findings showed that the kinetics of GR
and protein kinase degradation were very different in WT
cells treated with GA. Protein kinase degradation occurred
with a half-life of 12 min, whereas GR levels were greater
than 50% after 2 h. This difference may be accounted for in
the specialized chaperone complexes in which each client
type is engaged. Specifically, protein kinases interact with
Cdc37, whereas the GR does not.; it is Cdc37 interaction with
protein kinase–Hsp90 complexes that is the most labile upon
GA treatment. As previously demonstrated, Cdc37 plays an
active role in protecting newly synthesized protein kinases
against degradation, and it does so at distinct stages with
respect to translation and Hsp90 binding of the client (Man-
dal et al., 2007). It seems reasonable to propose that loss of
Cdc37 binding upon GA inhibition of Hsp90 results in ex-
posure of the unfolded protein kinase catalytic domain to
recognition components of the ubiquitin–proteasome sys-
tem in a manner dependent on Hsp70. This fits with the
notion that Cdc37 is absolutely required for protein kinase
folding. Because Sse1 promotes protein kinase degradation
it is likely that controlled release from Hsp70 is a required
step. For the GR, degradation is much slower in the presence
of GA. It is possible that Hsp70 and Hsp90 play more
important stabilizing functions in protecting the unfolded
receptor than for protein kinases, even in the presence of
GA. In this case, lack of Sse1 would shift the balance of
chaperone binding toward Hsp70 instead of Hsp90 because
polypeptide release is slowed by lack of the NEF. Further
work defining the nature of the transfer of distinct client
proteins between the Hsp70 and Hsp90 chaperone machin-
eries will be required to fully understand how the decision
is made to promote folding or degradation and how cochap-
erones including the Hsp110 proteins influence this process.
Figure 6. Hsp110 chaperones are restricted to
early stage Hsp90 complexes. (A) The isolated
Hsp110 nucleotide-binding domain from Sse2
traps Hsp90 early complex components. Flag-
resin affinity purifications from BY4741 cells
expressing either no tagged Sse (vec), Flag-
Sse1, or Flag-Sse2NBD are shown after separa-
tion with 10% SDS-PAGE and staining with
Coomassie brilliant blue. Protein identification
shown on the right was obtained through mass
spectrometry as described in Materials and
Methods. (B) Protein identities from A were
verified by immunoblot. (C) Sse1 copurifies
with the early stage Hsp90 complex. The indi-
cated strains expressing Flag-tagged early
(Sti1) or late (Sba1) Hsp90 cochaperones were
subject to Flag-resin affinity purification, SDS-
PAGE, and immunoblot as shown in A and B.
Figure 7. Client fate determination by Hsp70 and associated NEF
proteins. Client proteins are directed toward two distinct fates
within the Hsp70–Hsp90 chaperone system, as shown by large
block arrows. Sse1, functioning as a nucleotide exchange factor
(NEF), influences fate determination by Hsp70 through pathways A
(solid line arrow) and B (dashed line arrow) as described in the
Discussion. E3, E3 ubiquitin ligase; GA, geldanamycin.
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